Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Pathways (CLPA) -- Ignore unavailable to you. Want to Upgrade?

To: Dr. Seuss who wrote (271)	10/25/1999 11:45:00 AM
From: tuck	Read Replies (1) \| Respond to of 566

Dr. Seuss, Which round it is depends on when one joined the fray, of course, a matter of individual perspective. Filing the application and having it accepted are two different events. The acceptance of the filing means that the odds of ultimate approval are a little bit better than before. So I take issue with the "bogus misleading" part. No, it doesn't mean much, but it is slightly positive. And that's why a couple of y'all's foot soldiers have fallen these two sessions. If you're laughing your a** off, don't let it fall in the fish pond. Cheers, Tuck

To: Dr. Seuss who wrote (271)	10/25/1999 12:26:00 PM
From: Neuroguy	Read Replies (2) \| Respond to of 566

Seuss - are you really that stupid?? Maybe you are. The company didn't hype the information twice today - they are not Businesswire or Reuters! That's like saying someone is hyping themself because they got the cover of Time and Newsweek. CLPA was in Time recently....:) The acceptance of the filing is not the same as a submission. Shorts have said the FDA wouldn't accept the filing. They have. Shorts have said the drug doesn't work. It does. 1+1=2. The NDA will be approved. Please, for goodness' sake keep shorting at these levels. As for your future day job - I'd like my order Biggie sized, please!!! LOL